Browsing by Author "Subramaniam, Geetha"
Now showing 1 - 6 of 6
Results Per Page
Sort Options
Item Open Access A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.(Journal of addiction medicine, 2023-02) Bunting, Amanda M; Schwartz, Robert P; Wu, Li-Tzy; Wahle, Aimee; Kline, Margaret; Subramaniam, Geetha; McNeely, JenniferObjectives
This secondary analysis evaluated opioid-specific validation results of the Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS) tool for screening in primary care.Methods
This study is a secondary data analysis of the TAPS validation study. Performance of the TAPS tool for screening for unhealthy opioid use (with a score of 1+ for heroin and/or prescription opioids representing a positive screen) was evaluated. Discriminative ability was examined in comparison with reference standard measures across the spectrum of unhealthy opioid use: timeline follow-back with and without oral fluid testing identifying past-month use and the modified Composite International Diagnostic Interview for past-year problem use, opioid use disorder (OUD), and moderate-severe OUD.Results
In a sample of 2000 primary care patients, 114 screened positive for opioids on the TAPS tool. With a TAPS cutoff equal to 1+, the TAPS accurately identified past-month use, problem use, any OUD, and moderate-severe OUD (sensitivities = 68%-85%, specificities = 97%-98%, area under the curve = 0.80-0.91). When past-month use was expanded to include timeline follow-back with oral fluid testing, accuracy declined (52% sensitivity [95% confidence interval, 43%-60%], 98% specific [95% confidence interval, 97%-98%]).Conclusions
While further testing in a larger population sample may be warranted, given their brevity, simplicity, and accuracy when self-administered, the TAPS opioid items can be used in primary care settings for a spectrum of unhealthy opioid use; however, self-disclosure remains an issue in primary care settings.Item Open Access A Brief Screening and Assessment Tool for Opioid Use in Adults: Results from a Validation Study of the Tobacco, Alcohol, Prescription Medication, and Other Substances Tool.(Journal of addiction medicine, 2023-07) Bunting, Amanda M; Schwartz, Robert P; Wu, Li-Tzy; Wahle, Aimee; Kline, Margaret; Subramaniam, Geetha; McNeely, JenniferObjectives
This secondary analysis evaluated opioid-specific validation results of the Tobacco, Alcohol, Prescription Medication, and Other Substances (TAPS) tool for screening in primary care.Methods
This study is a secondary data analysis of the TAPS validation study. Performance of the TAPS tool for screening for unhealthy opioid use (with a score of 1+ for heroin and/or prescription opioids representing a positive screen) was evaluated. Discriminative ability was examined in comparison with reference standard measures across the spectrum of unhealthy opioid use: timeline follow-back with and without oral fluid testing identifying past-month use and the modified Composite International Diagnostic Interview for past-year problem use, opioid use disorder (OUD), and moderate-severe OUD.Results
In a sample of 2000 primary care patients, 114 screened positive for opioids on the TAPS tool. With a TAPS cutoff equal to 1+, the TAPS accurately identified past-month use, problem use, any OUD, and moderate-severe OUD (sensitivities = 68%-85%, specificities = 97%-98%, area under the curve = 0.80-0.91). When past-month use was expanded to include timeline follow-back with oral fluid testing, accuracy declined (52% sensitivity [95% confidence interval, 43%-60%], 98% specific [95% confidence interval, 97%-98%]).Conclusions
While further testing in a larger population sample may be warranted, given their brevity, simplicity, and accuracy when self-administered, the TAPS opioid items can be used in primary care settings for a spectrum of unhealthy opioid use; however, self-disclosure remains an issue in primary care settings.Item Open Access Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool(Addiction Science & Clinical Practice, 2019-12) Adam, Angéline; Schwartz, Robert P; Wu, Li-Tzy; Subramaniam, Geetha; Laska, Eugene; Sharma, Gaurav; Mili, Saima; McNeely, JenniferItem Metadata only Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients.(Ann Intern Med, 2016-11-15) McNeely, Jennifer; Wu, Li-Tzy; Subramaniam, Geetha; Sharma, Gaurav; Cathers, Lauretta A; Svikis, Dace; Sleiter, Luke; Russell, Linnea; Nordeck, Courtney; Sharma, Anjalee; O'Grady, Kevin E; Bouk, Leah B; Cushing, Carol; King, Jacqueline; Wahle, Aimee; Schwartz, Robert PBackground: Substance use, a leading cause of illness and death, is underidentified in medical practice. Objective: The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) tool was developed to address the need for a brief screening and assessment instrument that includes all commonly used substances and fits into clinical workflows. The goal of this study was to assess the performance of the TAPS tool in primary care patients. Design: Multisite study, conducted within the National Drug Abuse Treatment Clinical Trials Network, comparing the TAPS tool with a reference standard measure. (ClinicalTrials.gov: NCT02110693). Setting: 5 adult primary care clinics. Participants: 2000 adult patients consecutively recruited from clinic waiting areas. Measurements: Interviewer- and self-administered versions of the TAPS tool were compared with a reference standard, the modified World Mental Health Composite International Diagnostic Interview (CIDI), which measures problem use and substance use disorder (SUD). Results: Interviewer- and self-administered versions of the TAPS tool had similar diagnostic characteristics. For identifying problem use (at a cutoff of 1+), the TAPS tool had a sensitivity of 0.93 (95% CI, 0.90 to 0.95) and specificity of 0.87 (CI, 0.85 to 0.89) for tobacco and a sensitivity of 0.74 (CI, 0.70 to 0.78) and specificity of 0.79 (CI, 0.76 to 0.81) for alcohol. For problem use of illicit and prescription drugs, sensitivity ranged from 0.82 (CI, 0.76 to 0.87) for marijuana to 0.63 (CI, 0.47 to 0.78) for sedatives; specificity was 0.93 or higher. For identifying any SUD (at a cutoff of 2+), sensitivity was lower. Limitations: The low prevalence of some drug classes led to poor precision in some estimates. Research assistants were not blinded to participants' TAPS tool responses when they administered the CIDI. Conclusion: In a diverse population of adult primary care patients, the TAPS tool detected clinically relevant problem substance use. Although it also may detect tobacco, alcohol, and marijuana use disorders, further refinement is needed before it can be recommended broadly for SUD screening. Primary Funding Source: National Institute on Drug Abuse.Item Open Access Proceedings of the 13th annual conference of INEBRIA.(Addiction science & clinical practice, 2016-09) Watson, Rod; Morris, James; Isitt, John; Barrio, Pablo; Ortega, Lluisa; Gual, Antoni; Conner, Kenneth; Stecker, Tracy; Maisto, Stephen; Paroz, Sophie; Graap, Caroline; Grazioli, Véronique S; Daeppen, Jean-Bernard; Collins, Susan E; Bertholet, Nicolas; McNeely, Jennifer; Kushnir, Vlad; Cunningham, John A; Crombie, Iain K; Cunningham, Kathryn B; Irvine, Linda; Williams, Brian; Sniehotta, Falko F; Norrie, John; Melson, Ambrose; Jones, Claire; Briggs, Andrew; Rice, Peter; Achison, Marcus; McKenzie, Andrew; Dimova, Elena; Slane, Peter W; Grazioli, Véronique S; Collins, Susan E; Paroz, Sophie; Graap, Caroline; Daeppen, Jean-Bernard; Baggio, Stéphanie; Dupuis, Marc; Studer, Joseph; Gmel, Gerhard; Magill, Molly; Grazioli, Véronique S; Tait, Robert J; Teoh, Lucinda; Kelty, Erin; Geelhoed, Elizabeth; Mountain, David; Hulse, Gary K; Renko, Elina; Mitchell, Shannon G; Lounsbury, David; Li, Zhi; Schwartz, Robert P; Gryczynski, Jan; Kirk, Arethusa S; Oros, Marla; Hosler, Colleen; Dusek, Kristi; Brown, Barry S; Finnell, Deborah S; Holloway, Aisha; Wu, Li-Tzy; Subramaniam, Geetha; Sharma, Gaurav; Wallhed Finn, Sara; Andreasson, Sven; Dvorak, Robert D; Kramer, Matthew P; Stevenson, Brittany L; Sargent, Emily M; Kilwein, Tess M; Harris, Sion K; Sherritt, Lon; Copelas, Sarah; Knight, John R; The Partnership for Adolescent Substance Use Research; Mdege, Noreen D; McCambridge, Jim; Bischof, Gallus; Bischof, Anja; Freyer-Adam, Jennis; Rumpf, Hans-Juergen; Fitzgerald, Niamh; Schölin, Lisa; Toner, Paul; Böhnke, Jan R; Veach, Laura J; Currin, Olivia; Dongre, Leigh Z; Miller, Preston R; White, Elizabeth; Williams, Emily C; Lapham, Gwen T; Bobb, Jennifer J; Rubinsky, Anna D; Catz, Sheryl L; Shortreed, Susan; Bensley, Kara M; Bradley, Katharine A; Milward, Joanna; Deluca, Paolo; Khadjesari, Zarnie; Watson, Rod; Fincham-Campbell, Stephanie; Drummond, Colin; Angus, Kathryn; Bauld, Linda; Baumann, Sophie; Haberecht, Katja; Schnuerer, Inga; Meyer, Christian; Rumpf, Hans-Jürgen; John, Ulrich; Gaertner, Beate; Barrault-Couchouron, Marion; Béracochéa, Marion; Allafort, Vincent; Barthélémy, Valérie; Bonnefoi, Hervé; Bussières, Emmanuel; Garguil, Véronique; Auriacombe, Marc; Saint-Jacques, Marianne; Dorval, Michel; M’Bailara, Katia; Segura-Garcia, Lidia; Ibañez-Martinez, Nuria; Mendive-Arbeloa, Juan Manuel; Anoro-Perminger, Manel; Diaz-Gallego, Pako; Piñar-Mateos, Mª Angeles; Colom-Farran, Joan; Deligianni, Marianthi; Yersin, Bertrand; Adam, Angeline; Weisner, Constance; Chi, Felicia; Lu, Wendy; Sterling, Stacy; Kraemer, Kevin L; McGinnis, Kathleen A; Fiellin, David A; Skanderson, Melissa; Gordon, Adam J; Robbins, Jonathan; Zickmund, Susan; Korthuis, P Todd; Edelman, E Jennifer; Hansen, Nathan B; Cutter, Christopher J; Dziura, James; Fiellin, Lynn E; O’Connor, Patrick G; Maisto, Stephen A; Bedimo, Roger; Gilbert, Cynthia; Marconi, Vincent C; Rimland, David; Rodriguez-Barradas, Maria; Simberkoff, Michael; Justice, Amy C; Bryant, Kendall J; Berman, Anne H; Shorter, Gillian W; Bray, Jeremy W; Barbosa, Carolina; Johansson, Magnus; Hester, Reid; Campbell, William; Souza Formigoni, Maria Lucia O; Andrade, André Luzi Monezi; Sartes, Laisa Marcorela Andreoli; Sundström, Christopher; Eék, Niels; Kraepelien, Martin; Kaldo, Viktor; Fahlke, Claudia; Hernandez, Lynn; Becker, Sara J; Jones, Richard N; Graves, Hannah R; Spirito, Anthony; Diestelkamp, Silke; Wartberg, Lutz; Arnaud, Nicolas; Thomasius, Rainer; Gaume, Jacques; Grazioli, Véronique; Fortini, Cristiana; Malan, Zelra; Mash, Bob; Everett-Murphy, Katherine; Grazioli, Véronique S; Studer, Joseph; Mohler-Kuo, M; Bertholet, Nicolas; Gmel, Gerhard; Doi, Lawrence; Cheyne, Helen; Jepson, Ruth; Luna, Vanesa; Echeverria, Leticia; Morales, Silvia; Barroso, Teresa; Abreu, Ângela; Aguiar, Cosma; Stewart, Duncan; Abreu, Angela; Brites, Riany M; Jomar, Rafael; Marinho, Gerson; Parreira, Pedro; Seale, J Paul; Johnson, J Aaron; Henry, Dena; Chalmers, Sharon; Payne, Freida; Tuck, Linda; Morris, Akula; Gonçalves, Cátia; Besser, Bettina; Casajuana, Cristina; López-Pelayo, Hugo; Balcells, María Mercedes; Teixidó, Lídia; Miquel, Laia; Colom, Joan; Hepner, Kimberly A; Hoggatt, Katherine J; Bogart, Andy; Paddock, Susan M; Hardoon, Sarah L; Petersen, Irene; Hamilton, Fiona L; Nazareth, Irwin; White, Ian R; Marston, Louise; Wallace, Paul; Godfrey, Christine; Murray, Elizabeth; Sovinová, Hana; Csémy, LadislavItem Open Access VALIDATION OF THE 4-ITEM SCREENING COMPONENT OF THE TAPS TOOL TO IDENTIFY UNHEALTHY SUBSTANCE USE AMONG PRIMARY CARE PATIENTS(JOURNAL OF GENERAL INTERNAL MEDICINE, 2017-04-01) Schwartz, Robert; Gryczynski, Jan; McNeely, Jennifer; Wu, Litzy; Sharma, Gaurav; King, Jacquie; Jelstrom, Eve M; Nordeck, Courtney; Sharma, Anjalee; Mitchell, Shannon; O'Grady, Kevin; Svikis, Dace; Cathers, Lauretta; Subramaniam, Geetha